We should admit that the HTRA1 methylation alone is not sufficient as a screening tool, the combination of multiple biomarkers including blood-based DNA methylation profiles and others as well as stroke-related environmental factors might be a solution for the screening and prediction of stroke in preclinic. This evidence concerns the gene HTRA1 and Stroke.